Pre-existing antibody profiles related to immune-related adverse events in advanced non-small cell lung cancer patients treated with anti PD-1 antibody
Toi, Y., Sugawara, S., Sugisaka, J., Ono, H., Asou, M., Tsurumi, K., Suzuki, K., Shimizu, H., Domeki, Y., Aiba, T., Kawana, S., Saito, R., Terayama, K., Kawashima, Y., Nakamura, A., Yamanda, S., Kimura, Y., Honda, Y.
Published in Annals of oncology (01.11.2018)
Published in Annals of oncology (01.11.2018)
Get full text
Journal Article
Profiling of immune related adverse events from nivolumab or pembrolizumab monotherapy in advanced non-small cell lung cancer in real world
Aso, M., Sugawara, S., Toi, Y., Sugisaka, J., Ono, H., Tsurumi, K., Suzuki, K., Shimizu, H., Domeki, Y., Aiba, T., Kawana, S., Saito, R., Terayama, K., Kawashima, Y., Nakamura, A., Yamanda, S., Kimura, Y., Honda, Y.
Published in Annals of oncology (01.11.2018)
Published in Annals of oncology (01.11.2018)
Get full text
Journal Article
Pembrolizumab plus chemotherapy versus pembrolizumab monotherapy for PD-L1-positive advanced non-small cell lung cancer in the real world
Sugisaka, J., Sugawara, S., Toi, Y., Ogasawara, T., Aso, M., Tsurumi, K., Ono, K., Shimizu, H., Domeki, Y., Aiba, T., Kawana, S., Saito, R., Terayama, K., Kawashima, Y., Nakamura, A., Yamanda, S., Kimura, Y., Honda, Y.
Published in Annals of oncology (01.11.2019)
Published in Annals of oncology (01.11.2019)
Get full text
Journal Article
534PPre-existing antibody profiles related to immune-related adverse events in advanced non-small cell lung cancer patients treated with anti PD-1 antibody
Toi, Y, Sugawara, S, Sugisaka, J, Ono, H, Asou, M, Tsurumi, K, Suzuki, K, Shimizu, H, Domeki, Y, Aiba, T, Kawana, S, Saito, R, Terayama, K, Kawashima, Y, Nakamura, A, Yamanda, S, Kimura, Y, Honda, Y
Published in Annals of oncology (01.11.2018)
Published in Annals of oncology (01.11.2018)
Get full text
Journal Article
539PProfiling of immune related adverse events from nivolumab or pembrolizumab monotherapy in advanced non-small cell lung cancer in real world
Aso, M, Sugawara, S, Toi, Y, Sugisaka, J, Ono, H, Tsurumi, K, Suzuki, K, Shimizu, H, Domeki, Y, Aiba, T, Kawana, S, Saito, R, Terayama, K, Kawashima, Y, Nakamura, A, Yamanda, S, Kimura, Y, Honda, Y
Published in Annals of oncology (01.11.2018)
Published in Annals of oncology (01.11.2018)
Get full text
Journal Article
P1.16-34 Association Between Skin Reactions and Clinical Benefit in Patients Treated with Anti-PD-1 Treatment for Advanced Non-Small Cell Lung Cancer
Aso, M., Sugawara, S., Toi, Y., Sugisaka, J., Ono, H., Aiba, T., Kawana, S., Saito, R., Tsurumi, K., Ono, K., Shimizu, H., Domeki, Y., Terayama, K., Kawashima, Y., Nakamura, A., Yamanda, S., Kimura, Y., Honda, Y.
Published in Journal of thoracic oncology (01.10.2019)
Published in Journal of thoracic oncology (01.10.2019)
Get full text
Journal Article
P1.16-29 Profiling Immune-Related Adverse Events (irAEs) in Patients with Anti-PD-1 for Advanced Non-Small Cell Lung Cancer
Toi, Y., Sugawara, S., Aso, M., Tsurumi, K., Ono, K., Sugisaka, J., Shimizu, H., Ono, H., Domeki, Y., Aiba, T., Kawana, S., Saito, R., Terayama, K., Kawashima, Y., Nakamura, A., Yamanda, S., Kimura, Y., Honda, Y.
Published in Journal of thoracic oncology (01.10.2019)
Published in Journal of thoracic oncology (01.10.2019)
Get full text
Journal Article
P2.07-004 Immune-Related Adverse Events (irAEs) of Nivolumab Predicts Clinical Benefit in Advanced Lung Cancer Patients
Toi, Y., Sugawara, S., Kawashima, Y., Aiba, T., Tsurumi, K., Suzuki, K., Shimizu, H., Sugisaka, J., Ono, H., Domeki, Y., Kawana, S., Saito, R., Terayama, K., Nakamura, A., Yamanda, S., Kimura, Y., Honda, Y.
Published in Journal of thoracic oncology (01.11.2017)
Published in Journal of thoracic oncology (01.11.2017)
Get full text
Journal Article